FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nola Hylton

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Activities & Behaviors

Procedures

Anatomy

Breast

Phenomena

Magnetic Resonance Spectroscopy

Co-author Network

Publications

TOP 3
Constance D Lehman; Jeffrey D Blume; Wendy B Demartini; Benjamin Herman; Nola M Hylton; Mitchell D Schnall
Accuracy and interpretation time of computer-aided detection among novice and experienced breast MRI readers.
Silaja Yitta; Bonnie N Joe; Elissa R Price; Dorota J Wisner; Nola M Hylton
Recognizing artifacts and optimizing breast MRI at 1.5 and 3 T.
Jennifer F De Los Santos; Andres Forero; Mehra Golshan; Janet K Horton; Clifford A Hudis; Nola M Hylton; Kandace McGuire; Funda Meric-Bernstam; Ingrid M Meszoely; Rita Nanda; Keith D Amos; Alan Cantor; E Shelley Hwang
Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer: Translational Breast Cancer Research Consortium trial 017.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nola Hylton (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Constance D Lehman; Jeffrey D Blume; Wendy B Demartini; Benjamin Herman; Nola M Hylton; Mitchell D Schnall
Accuracy and interpretation time of computer-aided detection among novice and experienced breast MRI readers.
AJR. American journal of roentgenology 2013;200(6):W683-9.
2013: Silaja Yitta; Bonnie N Joe; Elissa R Price; Dorota J Wisner; Nola M Hylton
Recognizing artifacts and optimizing breast MRI at 1.5 and 3 T.
AJR. American journal of roentgenology 2013;200(6):W673-82.
2013: Jennifer F De Los Santos; Andres Forero; Mehra Golshan; Janet K Horton; Clifford A Hudis; Nola M Hylton; Kandace McGuire; Funda Meric-Bernstam; Ingrid M Meszoely; Rita Nanda; Keith D Amos; Alan Cantor; E Shelley Hwang
Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer: Translational Breast Cancer Research Consortium trial 017.
Cancer 2013;119(10):1776-83.
2013: Lisa J Wilmes; Dorota J Wisner; Suchandrima Banerjee; Bonnie N Joe; Ella F Jones; John Kornak; Rebekah L McLaughlin; David C Newitt; Evelyn Proctor; Emine U Saritas; Ajit Shankaranarayanan; Lisa Singer; Sumedha P Sinha; Nola M Hylton
High-resolution diffusion-weighted imaging for monitoring breast cancer treatment response.
Academic radiology 2013;20(5):581-9.
2013: Ella F Jones; C Klifa; John Kornak; David Newitt; Catherine Park; Sumedha P Sinha; Nola M Hylton
MRI Enhancement in Stromal Tissue Surrounding Breast Tumors: Association with Recurrence Free Survival following Neoadjuvant Chemotherapy.
PloS one 2013;8(5):e61969.
2012: Laura J Esserman; Dilip Giri; Joe W Gray; Cliff Hudis; Donald A Berry; Meredith Buxton; Lisa Carey; John T Carpenter; Yunn-Yi Chen; David Chhieng; Sarah E Davis; Angela DeMichele; Lynn Dressler; Helen Krontiras; Constance Lehman; Minetta C Liu; Chad Livasy; Carolyn Mies; Leslie Montgomery; Olufunmilayo I Olopade; Charles Perou; Joseph Rabban; Hope S Rugo; Baljit Singh; Debasish Tripathy; Laura van 't Veer; Christina Yau; Nola M Hylton
Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(26):3242-9.
2012: Nola M Hylton; Constance D Lehman; Helga S Marques; Elizabeth A Morris; Gillian M Newstead; Etta D Pisano; Sandra Polin; Mark A Rosen; Mitchell D Schnall; Paul T Weatherall; Wanda K Bernreuter; Jeffrey D Blume; Laura J Esserman
Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.
Radiology 2012;263(3):663-72.
2012: Lisa Singer; Lisa J Wilmes; Dorota J Wisner; Belinda Chang; Bonnie N Joe; Dwight G Nishimura; Evelyn Proctor; Emine U Saritas; Ajit Shankaranarayanan; Nola M Hylton
High-resolution diffusion-weighted magnetic resonance imaging in patients with locally advanced breast cancer.
Academic radiology 2012;19(5):526-34.
2011: Siyuan Liu; Ralph P Mason; Sameer J Shah; Michael F Wendland; Lisa J Wilmes; John Feiner; Harriet W Hopf; Nola M Hylton; Vikram D Kodibagkar; Mark D Rollins
Quantitative tissue oxygen measurement in multiple organs using 19F MRI in a rat model.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2011;66(6):1722-30.
2011: Savannah C Partridge; Lisa Singer; Ryan Sun; Lisa J Wilmes; Catherine S Klifa; Constance D Lehman; Nola M Hylton
Diffusion-weighted MRI: influence of intravoxel fat signal and breast density on breast tumor conspicuity and apparent diffusion coefficient measurements.
Magnetic resonance imaging 2011;29(9):1215-21.
2011: Vignesh A Arasu; Ryan C-Y Chen; David N Newitt; C Belinda Chang; Hilda Tso; Nola M Hylton; Bonnie N Joe
Can signal enhancement ratio (SER) reduce the number of recommended biopsies without affecting cancer yield in occult MRI-detected lesions?
Academic radiology 2011;18(6):716-21.
2011: C Klifa; S Suzuki; S Aliu; L Singer; Lisa J Wilmes; David Newitt; Bonnie N Joe; Nola M Hylton
Quantification of background enhancement in breast magnetic resonance imaging.
Journal of magnetic resonance imaging : JMRI 2011;33(5):1229-34.
2011: Chenjing Peng; C Belinda Chang; Hilda H Tso; Christopher I Flowers; Nola M Hylton; Bonnie N Joe
MRI appearance of tumor recurrence in myocutaneous flap reconstruction after mastectomy.
AJR. American journal of roentgenology 2011;196(4):W471-5.
2011: Nima Nabavizadeh; C Klifa; David Newitt; Ying Lu; Yunn-Yi Chen; Howard Hsu; Clark Fisher; Taku Tokayasu; Adam B Olshen; Paul Spellman; Joe Gray; Nola M Hylton; Catherine Park
Topographic enhancement mapping of the cancer-associated breast stroma using breast MRI.
Integrative biology : quantitative biosciences from nano to macro 2011;3(4):490-6.
2010: Elisabeth R Garwood; Anjali S Kumar; Frederick L Baehner; Dan H Moore; Alfred Au; Nola M Hylton; Chris I Flowers; Judy Garber; Beth-Ann Lesnikoski; E Shelley Hwang; Olofunmilao Olopade; Elisa Rush Port; Michael Campbell; Laura J Esserman
Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer.
Breast cancer research and treatment 2010;119(1):137-44.
2010: C Klifa; Julio Carballido-Gamio; Lisa J Wilmes; Anne Laprie; John Shepherd; Jessica Gibbs; Bo Fan; Susan Moyher Noworolski; Nola M Hylton
Magnetic resonance imaging for secondary assessment of breast density in a high-risk cohort.
Magnetic resonance imaging 2010;28(1):8-15.
2009: Amy J. Chien; Julie A Illi; Andrew H Ko; Wolfgang M Korn; Lawrence Fong; Lee-May Chen; Mohammed Kashani-Sabet; Charles J Ryan; Jonathan E Rosenberg; Sarita Dubey; Eric J Small; Thierry M Jahan; Nola M Hylton; Benjamin M Yeh; Yong Huang; Kevin M Koch; Mark M Moasser
A phase I study of a 2-day lapatinib chemosensitization pulse preceding nanoparticle albumin-bound Paclitaxel for advanced solid malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(17):5569-75.
2009: Nola M Hylton
Can diffuse optical spectroscopic tomography be used to characterize breast lesions and their response to treatment?
Radiology 2009;252(2):330-1.
2009: A D Barker; Caroline C Sigman; Gary J Kelloff; Nola M Hylton; D A Berry; L J Esserman
I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy.
Clinical pharmacology and therapeutics 2009;86(1):97-100.
2009: S O Aliu; Lisa J Wilmes; Mark M Moasser; Byron Hann; Ka-Loh Li; Danxin Wang; Nola M Hylton
MRI methods for evaluating the effects of tyrosine kinase inhibitor administration used to enhance chemotherapy efficiency in a breast tumor xenograft model.
Journal of magnetic resonance imaging : JMRI 2009;29(5):1071-9.
2009: Henry M Kuerer; Constance T Albarracin; Wei Tse Yang; Robert Cardiff; Abenaa M Brewster; W Fraser Symmans; Nola M Hylton; Lavinia P Middleton; Savitri Krishnamurthy; George H Perkins; Gildy Babiera; Mary E Edgerton; Brian J Czerniecki; Banu K Arun; Gabriel N Hortobagyi
Ductal carcinoma in situ: state of the science and roadmap to advance the field.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(2):279-88.
2008: Ka-Loh Li; Savannah C Partridge; Bonnie N Joe; Jessica E Gibbs; Ying Lu; Laura J Esserman; Nola M Hylton
Invasive breast cancer: predicting disease recurrence by using high-spatial-resolution signal enhancement ratio imaging.
Radiology 2008;248(1):79-87.
2008: Jona Hattangadi; Catherine Park; James Rembert; C Klifa; Jimmy Hwang; Jessica Gibbs; Nola M Hylton
Breast stromal enhancement on MRI is associated with response to neoadjuvant chemotherapy.
AJR. American journal of roentgenology 2008;190(6):1630-6.
2008: Thomas Buchholz; Constance D Lehman; Jay R Harris; Barbara A Pockaj; NAGI KHOURI; Nola M Hylton; Michael J Miller; Timothy Whelan; Lori J Pierce; Laura J Esserman; Lisa A Newman; Barbara L Smith; Harry D Bear; Eleftherios P Mamounas
Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(5):791-7.
2007: Mark M Moasser; Lisa J Wilmes; Ching-Hang Wong; Sheye Aliu; Ka-Loh Li; Donghui Wang; Yun Kit Hom; Byron Hann; Nola M Hylton
Improved tumor vascular function following high-dose epidermal growth factor receptor tyrosine kinase inhibitor therapy.
Journal of magnetic resonance imaging : JMRI 2007;26(6):1618-25.
2007: Ka-Loh Li; Roland G Henry; Lisa J Wilmes; Jessica Gibbs; Xiaoping Zhu; Ying Lu; Nola M Hylton
Kinetic assessment of breast tumors using high spatial resolution signal enhancement ratio (SER) imaging.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2007;58(3):572-81.
2007: Lisa J Wilmes; Maria G Pallavicini; Lisa M Fleming; Jessica Gibbs; Donghui Wang; Ka-Loh Li; Savannah C Partridge; Roland G Henry; David R Shalinsky; Dana Hu-Lowe; John W Park; Teresa M McShane; Ying Lu; Robert C Brasch; Nola M Hylton
AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
Magnetic resonance imaging 2007;25(3):319-27.
2007: Catherine S Klifa; Ann Shimakawa; Zaker Siraj; Jessica E Gibbs; Lisa J Wilmes; Savannah C Partridge; Evelyn Proctor; Nola M Hylton
Characterization of breast lesions using the 3D FIESTA sequence and contrast-enhanced magnetic resonance imaging.
Journal of magnetic resonance imaging : JMRI 2007;25(1):82-8.
2006: Laura J Esserman; Anjali S Kumar; Alex F Herrera; Jessica Leung; Alfred Au; Yunn-Yi Chen; Dan H Moore; Daniel F Chen; Jennifer Hellawell; Dulcy Wolverton; E Shelley Hwang; Nola M Hylton
Magnetic resonance imaging captures the biology of ductal carcinoma in situ.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(28):4603-10.
2006: Anjali S Kumar; Daniel F Chen; Alfred Au; Yunn-Yi Chen; Jessica Leung; Elisabeth R Garwood; Jessica Gibbs; Nola M Hylton; Laura J Esserman
Biologic significance of false-positive magnetic resonance imaging enhancement in the setting of ductal carcinoma in situ.
American journal of surgery 2006;192(4):520-4.
2006: Nola M Hylton
MR imaging for assessment of breast cancer response to neoadjuvant chemotherapy.
Magnetic resonance imaging clinics of North America 2006;14(3):383-9, vii.
2006: Nola M Hylton
Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(20):3293-8.
2006: Mitchell D Schnall; Jeffrey D Blume; David A Bluemke; Gia A DeAngelis; Nanette DeBruhl; Steven Harms; Sylvia H Heywang-Köbrunner; Nola M Hylton; Christiane Kuhl; Etta D Pisano; Petrina A Causer; Stuart J Schnitt; David Thickman; Carol B Stelling; Paul T Weatherall; Constance D Lehman; Constantine A Gatsonis
Diagnostic architectural and dynamic features at breast MR imaging: multicenter study.
Radiology 2006;238(1):42-53.
2005: Mitchell D Schnall; Jeffrey D Blume; David A Bluemke; Gia A DeAngelis; Nanette DeBruhl; Steven Harms; Sylvia H Heywang-Köbrunner; Nola M Hylton; Christiane Kuhl; Etta D Pisano; Petrina A Causer; Stuart J Schnitt; Stanley F Smazal; Carol B Stelling; Constance D Lehman; Paul T Weatherall; Constantine A Gatsonis
MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883.
Journal of surgical oncology 2005;92(1):32-8.
2005: Constance D Lehman; Jeffrey D Blume; David Thickman; David A Bluemke; Etta D Pisano; Christiane Kuhl; Thomas B Julian; Nola M Hylton; Paul T Weatherall; Michael O'loughlin; Stuart J Schnitt; Constantine A Gatsonis; Mitchell D Schnall
Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial.
Journal of surgical oncology 2005;92(1):9-15; discussion 15-6.
2005: Ka-Loh Li; Lisa J Wilmes; Roland G Henry; Maria G Pallavicini; John W Park; Dana Hu-Lowe; Teresa M McShane; David R Shalinsky; Y-J Fu; Robert C Brasch; Nola M Hylton
Heterogeneity in the angiogenic response of a BT474 human breast cancer to a novel vascular endothelial growth factor-receptor tyrosine kinase inhibitor: assessment by voxel analysis of dynamic contrast-enhanced MRI.
Journal of magnetic resonance imaging : JMRI 2005;22(4):511-9.
2005: Natasha Shah; Jessica Gibbs; Dulcy Wolverton; Albert Cerussi; Nola M Hylton; Bruce J Tromberg
Combined diffuse optical spectroscopy and contrast-enhanced magnetic resonance imaging for monitoring breast cancer neoadjuvant chemotherapy: a case study.
Journal of biomedical optics 2005;10(5):051503.
2005: Savannah C Partridge; Jessica E Gibbs; Ying Lu; Laura J Esserman; Debu Tripathy; Dulcy Wolverton; Hope S Rugo; E Shelley Hwang; Cheryl Ewing; Nola M Hylton
MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival.
AJR. American journal of roentgenology 2005;184(6):1774-81.
2005: Kathrin A Frei; Harald M Bonel; Marie-Françoise Pelte; Nola M Hylton; Karen Kinkel
Paget disease of the breast: findings at magnetic resonance imaging and histopathologic correlation.
Investigative radiology 2005;40(6):363-7.
2005: Constance D Lehman; Jeffrey D Blume; Paul T Weatherall; David Thickman; Nola M Hylton; Ellen Warner; Etta D Pisano; Stuart J Schnitt; Constantine A Gatsonis; Mitchell D Schnall; Gia A DeAngelis; Paul C Stomper; Eric L Rosen; Michael O'Loughlin; Steven Harms; David A Bluemke
Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.
Cancer 2005;103(9):1898-905.
2005: Nola M Hylton
Magnetic resonance imaging of the breast: opportunities to improve breast cancer management.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(8):1678-84.
2005: Ka-Loh Li; Xiaoping Zhu; Nola M Hylton; Geon-Ho Jahng; Michael Weiner; Norbert Schuff
Four-phase single-capillary stepwise model for kinetics in arterial spin labeling MRI.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2005;53(3):511-8.
2004: David A Bluemke; Constantine A Gatsonis; Mei Hsiu Chen; Gia A DeAngelis; Nanette DeBruhl; Steven Harms; Sylvia H Heywang-Köbrunner; Nola M Hylton; Christiane Kuhl; Constance D Lehman; Etta D Pisano; Petrina A Causer; Stuart J Schnitt; Stanley F Smazal; Carol B Stelling; Paul T Weatherall; Mitchell D Schnall
Magnetic resonance imaging of the breast prior to biopsy.
JAMA : the journal of the American Medical Association 2004;292(22):2735-42.
2004: C Klifa; Julio Carballido-Gamio; Lisa J Wilmes; Anne Laprie; C Lobo; E Demicco; M Watkins; J Shepherd; J Gibbs; Nola M Hylton
Quantification of breast tissue index from MR data using fuzzy clustering.
Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference 2004;3():1667-70.
2003: Nola M Hylton
Evaluation of gadobenate dimeglumine for contrast-enhanced MRI of the breast.
AJR. American journal of roentgenology 2003;181(3):677-8.
2003: E Shelley Hwang; Karen Kinkel; Laura J Esserman; Ying Lu; Noel Weidner; Nola M Hylton
Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: value in the diagnosis of residual disease, occult invasion, and multicentricity.
Annals of surgical oncology 2003;10(4):381-8.
2002: Savannah C Partridge; Jessica E Gibbs; Ying Lu; Laura J Esserman; Daniel Sudilovsky; Nola M Hylton
Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy.
AJR. American journal of roentgenology 2002;179(5):1193-9.
2002: Laura Esserman; Dulcy Wolverton; Nola M Hylton
Magnetic resonance imaging for primary breast cancer management: current role and new applications.
Endocrine-related cancer 2002;9(2):141-53.
2001: Savannah C Partridge; G C McKinnon; Roland G Henry; Nola M Hylton
Menstrual cycle variation of apparent diffusion coefficients measured in the normal breast using MRI.
Journal of magnetic resonance imaging : JMRI 2001;14(4):433-8.
2001: Laura Esserman; E Kaplan; Savannah C Partridge; Debu Tripathy; Hope S Rugo; J Park; Shelley Hwang; Henry M Kuerer; Daniel Sudilovsky; Ying Lu; Nola M Hylton
MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer.
Annals of surgical oncology 2001;8(6):549-59.
2001: Debra M Ikeda; Nola M Hylton; Karen Kinkel; M G Hochman; Christiane Kuhl; Werner A Kaiser; J C Weinreb; Stanley F Smazal; H Degani; P Viehweg; J Barclay; Mitchell D Schnall
Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies.
Journal of magnetic resonance imaging : JMRI 2001;13(6):889-95.
2001: Karen Kinkel; Nola M Hylton
Challenges to interpretation of breast MRI.
Journal of magnetic resonance imaging : JMRI 2001;13(6):821-9.
2001: Nola M Hylton
Vascularity assessment of breast lesions with gadolinium-enhanced MR imaging.
Magnetic resonance imaging clinics of North America 2001;9(2):321-32, vi.
2000: Kathrin A Frei; Karen Kinkel; Harald M Bonel; Y Lu; Laura J Esserman; Nola M Hylton
MR imaging of the breast in patients with positive margins after lumpectomy: influence of the time interval between lumpectomy and MR imaging.
AJR. American journal of roentgenology 2000;175(6):1577-84.
2000: L J Esserman; Dulcy Wolverton; Nola M Hylton
Integration of breast imaging into cancer management.
Current oncology reports 2000;2(6):572-81.
2000: Nola M Hylton
Suspension of breast-feeding following gadopentetate dimeglumine administration.
Radiology 2000;216(2):325-6.
2000: Karen Kinkel; T H Helbich; Laura J Esserman; J Barclay; E H Schwerin; Edward A Sickles; Nola M Hylton
Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability.
AJR. American journal of roentgenology 2000;175(1):35-43.
1999: Nola M Hylton
Dedicated Breast MRI Systems Working Group report.
Journal of magnetic resonance imaging : JMRI 1999;10(6):1006-9.
1999: Nola M Hylton
Vascularity assessment of breast lesions with gadolinium-enhanced MR imaging.
Magnetic resonance imaging clinics of North America 1999;7(2):411-20, x.
1999: Savannah C Partridge; E J Heumann; Nola M Hylton
Semi-automated analysis for MRI of breast tumors.
Studies in health technology and informatics 1999;62():259-60.
1999: Laura Esserman; Nola M Hylton; L Yassa; J Barclay; S Frankel; Edward A Sickles
Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(1):110-9.
1998: Nola M Hylton; Karen Kinkel
Technical aspects of breast magnetic resonance imaging.
Topics in magnetic resonance imaging : TMRI 1998;9(1):3-16.
1997: Nola M Hylton; C Allen
The development and use of SPIO Lycra compression bracing in children with neuromotor deficits.
Pediatric rehabilitation 1997;1(2):109-16.
1996: M W Bourne; L Margerun; Nola M Hylton; B Campion; J J Lai; nikita derugin; Charles B Higgins
Evaluation of the effects of intravascular MR contrast media (gadolinium dendrimer) on 3D time of flight magnetic resonance angiography of the body.
Journal of magnetic resonance imaging : JMRI 1996;6(2):3O5-1O.
1994: Nola M Hylton; S D Frankel
Imaging techniques for breast MR imaging.
Magnetic resonance imaging clinics of North America 1994;2(4):511-25.
1992: Nola M Hylton; I Simovsky; A J Li; J D Hale
Impact of section doubling on MR angiography.
Radiology 1992;185(3):899-902.
1990: Nola M Hylton; L N Du; M Winkler
MRA: how it's done and what it shows.
Diagnostic imaging 1990;12(6):117, 120-5.
1990: Nola M Hylton; W S Chung; E H Botvinick; N B Schiller; P Sheldon; L Kaufman
Oblique reformatting of multislice magnetic resonance images for improved visualization of coronary arteries.
Journal of digital imaging 1990;3(1):34-7.
1990: Nola M Hylton
Characterization of arterial blood flow using magnetic resonance imaging techniques.
Monographs on atherosclerosis 1990;15():32-42.
1988: L E Crooks; M Arakawa; Nola M Hylton; H Avram; J C Hoenninger; J C Watts; J D Hale; L Kaufman
Echo-planar pediatric imager.
Radiology 1988;166(1 Pt 1):157-63.
1987: T C Mills; D A Ortendahl; Nola M Hylton; L E Crooks; J W Carlson; L Kaufman
Partial flip angle MR imaging.
Radiology 1987;162(2):531-9.
1987: L E Crooks; Nola M Hylton; D A Ortendahl; J P Posin; L Kaufman
The value of relaxation times and density measurements in clinical MRI.
Investigative radiology 1987;22(2):158-69.
1986: D A Ortendahl; J P Posin; Nola M Hylton; C M Mills
Optimal visualization of the cerebrospinal fluid on MRI.
AJNR. American journal of neuroradiology 1986;7(3):403-7.
1986: Nola M Hylton; D A Ortendahl
Information processing in magnetic resonance imaging.
Critical reviews in diagnostic imaging 1986;26(4):325-58.
1985: J P Posin; D A Ortendahl; Nola M Hylton; L Kaufman; J C Watts; L E Crooks; C M Mills
Variable magnetic resonance imaging parameters: effect on detection and characterization of lesions.
Radiology 1985;155(3):719-25.
1985: D A Feinberg; C M Mills; J P Posin; D A Ortendahl; Nola M Hylton; L E Crooks; J C Watts; L Kaufman; M Arakawa; J C Hoenninger
Multiple spin-echo magnetic resonance imaging.
Radiology 1985;155(2):437-42.
1984: D A Ortendahl; Nola M Hylton; L Kaufman; J C Watts; L E Crooks; C M Mills; D D Stark
Analytical tools for magnetic resonance imaging.
Radiology 1984;153(2):479-88.
1984: D A Ortendahl; Nola M Hylton; L Kaufman; L E Crooks
Signal to noise in derived NMR images.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 1984;1(3):316-38.
1984: M Brant-Zawadzki; H M Bartkowski; D A Ortendahl; Lawrence H Pitts; Nola M Hylton; M C Nishimura; L E Crooks
NMR in experimental cerebral edema: value of T1 and T2 calculations.
AJNR. American journal of neuroradiology 1984;5(2):125-9.